Flanagan Glenda J 4/A
4/A · Vital Farms, Inc. · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
Vital Farms (VITL) Director Glenda Flanagan Buys 6,100 Shares
What Happened
Director Glenda J. Flanagan purchased 6,100 shares of Vital Farms (VITL) in an open-market transaction on May 18, 2026. The reported weighted-average price was $8.33 per share for a total outlay of $50,813. This filing is an amendment clarifying that the transaction was a purchase.
Key Details
- Transaction date: 2026-05-18 (open market purchase; transaction code P).
- Price: weighted-average $8.33; trades occurred at prices in the $8.33–$8.34 range (per footnote).
- Total value: $50,813 for 6,100 shares.
- Shares owned after the transaction: not disclosed in this amended Form 4.
- Footnote: reporting person can provide a breakdown of the number of shares bought at each separate price within the reported range upon request.
- Filing status: this is a Form 4/A filed 2026-05-21 amending the original Form 4 filed 2026-05-20 to clarify the footnote; the original filing appears timely.
Context
Purchases by insiders can be of interest to investors as a potential bullish signal, though they do not by themselves indicate motivation. This is a relatively modest open-market purchase (~$50.8K). The amendment only clarifies transaction details; no derivative exercises, gifts, or tax-withholding transactions are reported.
Insider Transaction Report
Form 4/AAmended
Flanagan Glenda J
Director
Transactions
- Purchase
Common Stock
[F1]2026-05-18$8.33/sh+6,100$50,813→ 37,498 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.33 to $8.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Signature
/s/ Francis Cullo, Attorney-in-Fact|2026-05-21